Answers are grounded in this paper and cite their sources.
Objectives To study whether HHV-6B can act as a molecular mimic to trigger onset of Type One Diabetes Mellitus (T1DM) by assessing structural and binding similarities between HHV-6B derived epitopes and T1DM autoantigen derived epitopes. Methods Epitope peptide structures and their interactions with T1DM autoantigens were modeled using Boltz-2, a state-of-the-art artificial intelligence protein structure prediction method. Results Several HHV-6B epitopes studied here demonstrated high structural alignment with T1DM antigen epitopes, but even when structural homology was lacking, in multiple cases the HHV-6B and T1DM epitopes fit into the same binding region of the corresponding HLA molecules, suggesting a plausible structural basis for T cell cross-reactivity. These findings support the hypothesis that HHV-6B may act as a molecular mimic contributing to autoimmune responses in individuals genetically susceptible to T1DM. Conclusion This study demonstrates that structural modeling is a useful tool for identifying potential mimicry candidates that sequence-based methods may not find, underscoring the importance of integrating structure-based modeling, including docking, into molecular mimicry prediction pipelines for identifying potential epitopes for in vitro studies.
No takes yet. Share an insight, caveat, or question.
Jones et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: